Boumenot Peter 4
4 · Signify Health, Inc. · Filed Feb 17, 2021
Insider Transaction Report
Form 4
Boumenot Peter
Chief Product Officer
Transactions
- Award
Class B Common Stock
2021-02-12$0.01/sh+186,038$1,860→ 186,038 total - Award
LLC Units in Cure Aggregator, LLC
2021-02-12+161,865→ 161,865 total→ Class A Common Stock (161,865 underlying) - Award
LLC Units in Cure Aggregator, LLC
2021-02-12+24,173→ 24,173 total→ Class A Common Stock (24,173 underlying)
Footnotes (3)
- [F1]These securities were acquired through the conversion prior to the completion of the Issuer's initial public offering of historical interests held by the reporting person in Cure Aggregator, LLC.
- [F2]The LLC Units service-vest 25% on each of December 31, 2019, 2020, 2021 and 2022 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.
- [F3]The LLC Units service-vest 25% on each of the first four anniversaries of November 27, 2019 and performance-vest based on the achievement by New Mountain Capital, LLC and its affiliates of specified cash-on-cash return thresholds. Upon vesting, each LLC Unit may be converted by the holder into an LLC Unit of Cure TopCo, LLC, which may thereafter be redeemed for, together with the cancellation of a share of Class B common stock, one share of Class A common stock or a cash payment equal to the volume weighted average market price of one share of Class A common stock for each LLC Unit redeemed. The LLC Units do not expire.